Tony W Ho

CIK 1713637 · Executive VP, Head of R&D · last filed 2024-06-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.24M

Companies

3

Total Filings

22

Lifetime Open-Market Net

-$4.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
iTeos Therapeutics, Inc. (ITOS) Delisted Director $10.15 $0 5 2024-06-13
CRSP Executive VP, Head of R&D 64,971 $49.80 $3.24M -$4.52M 16 2021-12-07
CRISPR Therapeutics AG (PZRX) Delisted See Remarks $0 1 2017-08-02

Recent Filings · Page 2 of 3

22 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-10-06 CRSP Grant (A) $0 EDGAR
2020-06-24 CRSP Sell (S) −7,158 -$537.1K EDGAR
2020-05-27 CRSP Sell (S) −6,700 -$469.9K EDGAR
2020-03-12 CRSP Grant (A) $0 EDGAR
2020-03-09 CRSP Mixed +1,770 -$82.3K EDGAR
2019-12-05 CRSP Grant (A) $0 EDGAR
2019-08-05 CRSP Mixed +22,966 -$763.9K EDGAR
2019-03-07 CRSP Grant (A) +10,000 $408.7K EDGAR
2018-08-03 CRSP Mixed +22,869 -$708.6K EDGAR
2018-06-15 CRSP Grant (A) $0 EDGAR
Showing 1120 of 22
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.